EN | UA
EN | UA

Help Support

Back

Comparison of three minoxidil-based regimens in androgenetic alopecia

Androgenetic alopecia Androgenetic alopecia
Androgenetic alopecia Androgenetic alopecia

Androgenetic alopecia (AGA) is often managed with topical minoxidil, though alternative approaches such as platelet-rich plasma (PRP) therapy and low-dose oral minoxidil have emerged.

See All

Key take away

Combining platelet-rich plasma with topical minoxidil yields the greatest increase in terminal hair density, while low-dose oral minoxidil shows the highest reduction in vellus hair density in androgenetic alopecia treatment.

Background

Androgenetic alopecia (AGA) is often managed with topical minoxidil, though alternative approaches such as platelet-rich plasma (PRP) therapy and low-dose oral minoxidil have emerged. This randomized controlled trial aimed to explore the effectiveness of low-dose oral minoxidil, topical minoxidil, and PRP + topical minoxidil in AGA.

Method

In total, 75 participants were randomly allocated into 3 groups (25 per group), with 60 completing the 32-week follow-up:

  • Group 1: Oral minoxidil
  • Group 2: Topical minoxidil
  • Group 3: Combination of PRP with topical minoxidil

Assessments, both clinical and videodermoscopic, were carried out at regular intervals.

Result

By week 32, a one-grade improvement in AGA severity was seen in 25% of patients in Groups 1 and 3, and 10% in Group 2. The median increase in terminal hair density was highest in Group 3 (57%), followed by Group 2 (48%) and Group 1 (47.5%), with statistically significant differences favoring Group 3 over both others. Conversely, the greatest reduction in vellus hair density was noted in Group 1 (26%), outperforming Group 3 (19%).

All groups exhibited a prominent reduction in hair diameter variability by week 32, with no notable differences between them. Side effects were usually mild. Group 1 experienced headaches (20%), dizziness (15%), and pedal edema (5%). Group 2 experienced scalp dryness and itching in 75% of cases. In Group 3, all patients felt temporary pain during PRP sessions, with minor bleeding in 15% and dizziness in 5%. Despite these adverse events, most volunteers tolerated the treatments well.

Conclusion

The findings support low-dose oral minoxidil as a viable alternative to the topical form and highlight the added benefit of combining topical minoxidil with PRP for enhanced results.

Source:

Archives of Dermatological Research

Article:

Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial

Authors:

Janaani et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: